Review
Open access
Oct 2026
Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective
Background/Objectives: Obesity is a chronic, multifactorial condition driven by complex neuroendocrine and metabolic pathways that limit the long-term success of lifestyle interventions. Pharmacotherapy has advanced from early monoaminergic agents to incretin-based and multi-receptor agonists with substantially improve...
Ishtiaque Ahmad, Sarfuddin Azmi, Monirah A. Albabtain et al.
· Pharmaceutics · 0 citations